Suppression of Type I Interferon Signaling by Flavivirus NS5.

Type I interferon (IFN-I) is the first line of mammalian host defense against viral infection. To counteract this, the flaviviruses, like other viruses, have encoded a variety of antagonists, and use a multi-layered molecular defense strategy to establish their infections. Among the most potent antagonists is non-structural protein 5 (NS5), which has been shown for all disease-causing flaviviruses to target different steps and players of the type I IFN signaling pathway. Here, we summarize the type I IFN antagonist mechanisms used by flaviviruses with a focus on the role of NS5 in regulating one key regulator of type I IFN, signal transducer and activator of transcription 2 (STAT2)

Structure and function of Zika virus NS5 protein: perspectives for drug design.

Zika virus (ZIKV) belongs to the positive-sense single-stranded RNA-containing Flaviviridae family. Its recent outbreak and association with human diseases (e.g. neurological disorders) have raised global health concerns, and an urgency to develop a therapeutic strategy against ZIKV infection. However, there is no currently approved antiviral against ZIKV. Here we present a comprehensive overview on recent progress in structure-function investigation of ZIKV NS5 protein, the largest non-structural protein of ZIKV, which is responsible for replication of the viral genome, RNA capping and suppression of host interferon responses. Structural comparison of the N-terminal methyltransferase domain and C-terminal RNA-dependent RNA polymerase domain of ZIKV NS5 with their counterparts from related viruses provides mechanistic insights into ZIKV NS5-mediated RNA replication, and identifies residues critical for its enzymatic activities. Finally, a collection of recently identified small molecule inhibitors against ZIKV NS5 or its closely related flavivirus homologues are also discussed

Structural and Functional Characterizations of Flavivirus NS5: Perspective for Drug Discovery and Vaccine Development

Flaviviruses have historically caused severe epidemics or pandemics, but few therapies are available currently. NS5 is a critical enzyme responsible for fiaviviral life cycle, and suppresses host immune response via host-pathogen interaction as well. In this study, we determined the crystal structure of Zika virus (ZIKV), a member of flavivirus family, revealing flavivirus NS5 proteins share a conserved domain conformation. A small molecule inhibitor, I29, was subsequently proved to bind to ZIKV NS5. Meanwhile, we solved the structure of ZIKV NS5 in complex with its host partner, human STAT2 (hSTAT2), suggesting a bypass pathway to interfere immune response. We were able to rescue viral strains with mutations of residues involved in hSTAT2-binding, providing novel insights into vaccine development

Suppression of Type I Interferon Signaling by Flavivirus NS5.

Type I interferon (IFN-I) is the first line of mammalian host defense against viral infection. To counteract this, the flaviviruses, like other viruses, have encoded a variety of antagonists, and use a multi-layered molecular defense strategy to establish their infections. Among the most potent antagonists is non-structural protein 5 (NS5), which has been shown for all disease-causing flaviviruses to target different steps and players of the type I IFN signaling pathway. Here, we summarize the type I IFN antagonist mechanisms used by flaviviruses with a focus on the role of NS5 in regulating one key regulator of type I IFN, signal transducer and activator of transcription 2 (STAT2)